Lori Styles

8.7k citations
95 papers · 5.2k · 1 hit paper · h-index 42

Impact in

  • Genetics top 0.05%
    • Hemoglobinopathies and Related Disorders
    • Chronic Lymphocytic Leukemia Research
    • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Hematology top 0.2%
    • Iron Metabolism and Disorders
    • Blood groups and transfusion
    • Hematopoietic Stem Cell Transplantation

Papers in

    • Hemoglobinopathies and Related Disorders 67
    • Chronic Lymphocytic Leukemia Research 19
    • Myeloproliferative Neoplasms: Diagnosis and Treatment 7
    • Iron Metabolism and Disorders 19
    • Blood groups and transfusion 13
    • Chronic Myeloid Leukemia Treatments 10

Lori Styles

94 papers receiving 4.9k citations

Lori Styles's Hit Papers

Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trial 2018 · 393 citations
3930+2+5Years since publication100200300

Peers

Lori Styles
Comparison fields: 5 of 102
  • Genetics 3.9k
  • Hematology 2.7k
  • Pediatrics, Perinatology and Child Health 631
  • Physiology 661
  • Pathology and Forensic Medicine 410
Replace Kenneth I. Ataga with:
Kenneth I. Ataga United States
Caterina P. Minniti United States
S Richards United Kingdom
Elizabeth A. Manci United States
Lawrence A. Solberg United States
Michelle A. Elliott United States
Denis R. Miller United States
Cage S. Johnson United States
Attilio Rovelli Italy
Murray N. Silverstein United States
Lori Styles relative to Kenneth I. Ataga United States Kenneth I. Ataga's profile →
Citations per field
00.5×5×10×14.6×
Kenneth I. Ataga · 1×
Citations per year

Countries citing papers authored by Lori Styles

Since Specialization
Citations

This map shows the geographic impact of Lori Styles's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lori Styles with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lori Styles more than expected).

Fields of papers citing papers by Lori Styles

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lori Styles. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lori Styles. The network helps show where Lori Styles may publish in the future.

Co-authors

The 25 scholars most cited alongside Lori Styles, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lori Styles Line = papers co-authored together Lori Styles links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 95 papers — load more, or switch the sort, to bring in the rest.

#Work
1 1997446
2
Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trial
Hit paper breakdown →
2018393
3 2017334
4 1998204
5 2001191
6 1998179
7 1998173
8 2000171
9 2003134
10 2002134
11 1997132
12 2006119
13 2000105
14 2001103
15 200095
16 200290
17 199883
18 199483
19 200081
20 200778

About Lori Styles

Lori Styles is a scholar working on Genetics, Hematology, Pediatrics, Perinatology and Child Health, Cell Biology and Pathology and Forensic Medicine, having authored 95 papers that have together received 5.2k indexed citations. Recurring topics across this work include Hemoglobinopathies and Related Disorders (67 papers), Iron Metabolism and Disorders (19 papers), Chronic Lymphocytic Leukemia Research (19 papers), Blood groups and transfusion (13 papers), Chronic Myeloid Leukemia Treatments (10 papers), Neonatal Health and Biochemistry (9 papers), Hemoglobin structure and function (8 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (7 papers). The work is most often cited by research in Genetics (3.9k citations), Hematology (2.7k citations), Pediatrics, Perinatology and Child Health (631 citations), Physiology (661 citations) and Pathology and Forensic Medicine (410 citations). Lori Styles has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Elliott Vichinsky, Frans A. Kuypers, Sandra Larkin, Carolyn Hoppe, Elizabeth C. Wright, Oswaldo Castro, Bruce G. Nickerson, Linda H. Colangelo, Claudia R. Morris and Nigel S. Key. Their work appears in journals such as Blood, British Journal of Haematology, American Journal of Hematology, Journal of Pediatric Hematology/Oncology and The Journal of Pediatrics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact